Abingdon Health Share Price (ABDX)

[ADVERT]

Share Name	Share Symbol	Market	Type	Share ISIN	Share Description
Abingdon Health Plc	LSE:ABDX	London	Ordinary Share	GB00BLF79J41	ORD 0.025P

	Price Change	% Change	Share Price	Shares Traded	Last Trade
	-10.00	-26.32%	28.00	2,657,949	10:18:22

Bid Price		Offer Price	High Price	Low Price	Open Price
27.00		29.00	30.50	26.50	29.00

Industry Sector	Turnover (m)	Profit (m)	EPS - Basic	PE Ratio	Market Cap (m)
Health Care Equipment & Services					27

Last Trade Time	Trade Type	Trade Size	Trade Price	Currency
10:19:00	O	10,000	28.47	GBX

Related Shares
Smith & Nephew (SN.), Convatec (CTEC), Widecells (WDC), Salvarx (SALV)

Abingdon Health (ABDX) Latest News (8)

Abingdon Health News

Date	Time	Source	Headline
01/12/2021	10:18	UKREG	Abingdon Health PLC Close of Accelerated Bookbuild & PrimaryBid Offer
01/12/2021	09:05	UKREG	Abingdon Health PLC Second Price Monitoring Extn
01/12/2021	09:00	UKREG	Abingdon Health PLC Price Monitoring Extension
01/12/2021	07:00	UKREG	Abingdon Health PLC Proposed Fundraising
18/11/2021	20:53	ALNC	TRADING UPDATES: Abingdon Health swings to loss; MetalNRG in dispute
18/11/2021	16:41	UKREG	Abingdon Health PLC Second Price Monitoring Extn
18/11/2021	16:35	UKREG	Abingdon Health PLC Price Monitoring Extension
18/11/2021	14:05	UKREG	Abingdon Health PLC Second Price Monitoring Extn
18/11/2021	14:00	UKREG	Abingdon Health PLC Price Monitoring Extension
18/11/2021	11:06	UKREG	Abingdon Health PLC Second Price Monitoring Extn

More Abingdon Health News

Abingdon Health Investors Abingdon Health Takeover Rumours

Abingdon Health (ABDX) Share Charts 1 Year Abingdon Health Chart
1 Month Abingdon Health Chart	Intraday Abingdon Health Chart

Abingdon Health (ABDX) Discussions and Chat

Abingdon Health Forums and Chat

Date	Time	Title	Posts
01/12/2021	10:16	Abingdon Health: Lateral Flow Diagnostics	1,171
05/11/2021	10:09	freeFor all rampngFree	60

Add a New Thread

Abingdon Health (ABDX) Most Recent Trades

Trade Time	Trade Price	Trade Size	Trade Value	Trade Type
10:18:24	27.85	10,757	2,995.82	O
10:18:16	27.85	17,932	4,994.06	O
10:12:41	27.85	1,034	287.97	O
10:10:39	27.77	17,963	4,988.33	O
10:07:59	27.51	10,000	2,751.00	O

View all Abingdon Health trades in real-time

Abingdon Health (ABDX) Top Chat Posts

Date	Subject
01/12/2021 08:20	Abingdon Health Daily Update: Abingdon Health Plc is listed in the Health Care Equipment & Services sector of the London Stock Exchange with ticker ABDX. The last closing price for Abingdon Health was 38p. Abingdon Health Plc has a 4 week average price of 26.50p and a 12 week average price of 26.50p. The 1 year high share price is 133.50p while the 1 year low share price is currently 26p. There are currently 95,699,114 shares in issue and the average daily traded volume is 847,031 shares. The market capitalisation of Abingdon Health Plc is £27,274,247.49. Read Full Thread Reply
01/12/2021 08:34	pwhite73: volsung 18 Nov - "Bought a few more at 37.8p Mind you the lesson seems to be sell ABDX on the spikes lol" The lesson seems to be you're not actually learning anything volsung. Told you to avoid ABDX and AVCT. Read Full Thread Follow Reply
01/12/2021 07:33	columbarius: Lots of warnings about this. Like on the ODX boards there are too many useless investors spouting nonsense on this thread. columbarius - 15 Sep 2021 - 17:12:16 - 574 of 1143 I think it obvious they need cash. How many times with aim companies have we seen a share price jump then decline into a placing as insiders benefit from knowledge of the placing price. Read Full Thread Follow Reply
04/11/2021 14:56	amd75: Why share price is dropping ? Any idea guys Read Full Thread Follow Reply
21/10/2021 13:22	bamboo2: eddy, I would chill out. Don't let others' views depress you. They are guilty of bias in talking their own book. Ask yourself, why would someone spend time making up negative stories? I can guarantee they are not doing it for free! They are trying to influence the share price by creating a climate of fear. Posts don't even need to contain any facts to create negativity. Jaks post is partly true, but leaves out the main reason why a large amount of capital was spent, ie a new factory was built, and an existing one upgraded. In fact the upgrade was planned long before covid, and was the main reason for the capital raise and listing. Vatic is just around the corner. Changes to the requirements for LFT's are due tomorrow, things could then get much more interesting. Whenever someone posts something negative, just copy and past this one below it! Read Full Thread Follow Reply
06/10/2021 13:03	monte1: To correct a few inaccuracies; 1. Agreed no need for an RNS because although an agreement exists between Vatican/abdx, this would only become material when meaningful manufactured volume has been ordered under the contract. 2. The test has been approved currently for professional use only. A variation of the test is under development for home use which, if approved, will cater to a much increased market place. 3. The DHSC have never stated that the test kits supplied in 2020 do not work. They took delivery and have been using the tests. Their supply has been caught up in allegations of ‘preferential treatment’ granted to abdx by the purchasers which abdx have disputed in detail. This will form part of the GLP instigated judicial review. The DHSC contract provided the right to cancel by 25/12/20 if the tests were not by that time approved for home use. They weren’t and as a result only 1m of a potential 10m order was called off and delivered under the contract which, in any event, expired in Feb 21. Read Full Thread Follow Reply
06/10/2021 07:47	pwhite73: The Abingdon/Vatic story is completely bogus. US regulators are much tougher against this kind of behaviour. At the start of the pandemic the SEC suspended several companies including SCworx for putting out questionable orders to boost the share price. https://seekingalpha.com/news/3563088-sec-suspends-trading-in-scworx-over-covidminus-19-test-issue "The SEC has halted trading in SCWorx (WORX) in apparent response to concerns over its previously announced multimillion-test order for COVID-19 blood tests. On April 13, the company announced that it received an order for 2M tests from virtual healthcare network Rethink My Healthcare with a provision for additional orders for 2M tests per week for 23 weeks, an order it confirmed on April 17 after short seller Hindenburg Research published a report questioning its veracity." Read Full Thread Follow Reply
22/9/2021 19:10	jaforsadi: Abdx will outshine odx and avct tomorrow. Thats fact. Mainly due to the fact that mcap of abdx is 45m compared to odx which is 96m and avct which is already an eye wayering 319m.Abdx is the one to jump on Read Full Thread Follow Reply
15/9/2021 17:21	johncraven2: So what price is the placing? BR is saying 10p. They have to satisfy the IPO holders, allowing them to average down big. Otherwise, the price will plummet a lot more when IPO holders start dumping in 3 months time. Either way, it does not bode well for the share price. It will be difficult to get enough to survive for the next six months. Could be the shortest IPO ever, as administration is clearly in play now. No contract. Read Full Thread Follow Reply
25/8/2021 10:02	bmwman3: Credit to joshholdforgold on LSE Share price forecastshare price forecastAssumptions: Enterprise Value = 12x gross profit for non-covid related revenue.Enterprise Value = 6x gross profit for covid related revenue. Non covid revenue = £3.5m H1 2021FY2021 Rev = £7mGross Profit Margin 40%GP = £2.7mFactor x12EV=£32.4mAntibody testrevenue = £33 x margin x sales Gross profit margin (est.) 40%Sales (est.) = 1m/year GP = £13.2mFactor x6EV=£79mNow my projections for the lateral flow test sales relies on my firm belief that AVCT will in the next few weeks receive Home Ise Authorisation for their best in class test. At this point their manufacturing agreement with ABDX will kick in and we can expect orders of 4m tests per month. AVCT test revenue = £5 x margin x sales Gross profit margin (est.) 20%Sales (est.) = 48m/year GP = £46mFactor x6EV=£276mWithout any provision for sales of Abingdon's own covid products we reach a the following valuations:Without AVCT sales:£111.4m = £1.15 per shareWith AVCT sales:£387.4m = £3.99 per share Read Full Thread Follow Reply
24/8/2021 07:47	garth: NYB, Thanks for clarifying. On that timescale I expect interesting times in between and some volatility here. But a share price at ABDX north of where it is now. GLH. G. Read Full Thread Follow Reply

Abingdon Health share price data is direct from the London Stock Exchange

Advertise Here

Your Recent History

LSE

ABDX

Abingdon H..

Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

ADVFN UK Investors Hub ADVFN Italy ADVFN Australia ADVFN Brazil

ADVFN Canada ADVFN Germany ADVFN Japan ADVFN Mexico

ADVFN France ADVFN US

P: V: D:20211201 10:34:19